A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the intercontinental childhood ITP study group

Thomas Kühne, George R. Buchanan, Sherri Zimmerman, Lisa A. Michaels, Regina Kohan, Willi Berchtold, Paul Imbach

Research output: Contribution to journalArticle

197 Citations (Scopus)

Abstract

Objective: To analyze prospectively the impact of age at diagnosis in childhood idiopathic thrombocytopenic purpura (ITP). Study design: International registry from June 1997 to May 2001, with analysis of data from baseline and 6-month-follow-up questionnaires. Results: Data from 2540 patients were analyzed, including 203 infants (7.6%), 1860 children ≥1 to <10 years of age (69.1%), and 477 children and adolescents between ≥10 and <16 years of age (17.7%). The mean platelet count at diagnosis was similar in all three groups, as was the percentage of patients with initial platelet count <20 × 109/L. The male/female ratio was highest in infants and decreased with age (P = .009). Immunoglobulin therapy was used more often in infants and corticosteroids in patients ≥10 years of age. Follow-up information at 6 months was available for 1742 children (68.6%). Chronic ITP was seen less frequently in infants (23.1%) than in children >10 years of age (47.3%, P < .0001). Intracranial hemorrhage occurred in 3 of 1742 children during the first 6 months after the diagnosis of ITP. Conclusions: Pediatric patients with ITP from infancy to adolescence exhibit heterogeneity in clinical, demographic, and treatment factors.

Original languageEnglish (US)
Pages (from-to)605-608
Number of pages4
JournalJournal of Pediatrics
Volume143
Issue number5
DOIs
StatePublished - Nov 2003

Fingerprint

Idiopathic Thrombocytopenic Purpura
Prospective Studies
Intracranial Hemorrhages
Registries
Demography
Pediatrics
Therapeutics

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the intercontinental childhood ITP study group. / Kühne, Thomas; Buchanan, George R.; Zimmerman, Sherri; Michaels, Lisa A.; Kohan, Regina; Berchtold, Willi; Imbach, Paul.

In: Journal of Pediatrics, Vol. 143, No. 5, 11.2003, p. 605-608.

Research output: Contribution to journalArticle

Kühne, Thomas ; Buchanan, George R. ; Zimmerman, Sherri ; Michaels, Lisa A. ; Kohan, Regina ; Berchtold, Willi ; Imbach, Paul. / A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the intercontinental childhood ITP study group. In: Journal of Pediatrics. 2003 ; Vol. 143, No. 5. pp. 605-608.
@article{b5ca4095111845d1b83ab6bc7ab95974,
title = "A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the intercontinental childhood ITP study group",
abstract = "Objective: To analyze prospectively the impact of age at diagnosis in childhood idiopathic thrombocytopenic purpura (ITP). Study design: International registry from June 1997 to May 2001, with analysis of data from baseline and 6-month-follow-up questionnaires. Results: Data from 2540 patients were analyzed, including 203 infants (7.6{\%}), 1860 children ≥1 to <10 years of age (69.1{\%}), and 477 children and adolescents between ≥10 and <16 years of age (17.7{\%}). The mean platelet count at diagnosis was similar in all three groups, as was the percentage of patients with initial platelet count <20 × 109/L. The male/female ratio was highest in infants and decreased with age (P = .009). Immunoglobulin therapy was used more often in infants and corticosteroids in patients ≥10 years of age. Follow-up information at 6 months was available for 1742 children (68.6{\%}). Chronic ITP was seen less frequently in infants (23.1{\%}) than in children >10 years of age (47.3{\%}, P < .0001). Intracranial hemorrhage occurred in 3 of 1742 children during the first 6 months after the diagnosis of ITP. Conclusions: Pediatric patients with ITP from infancy to adolescence exhibit heterogeneity in clinical, demographic, and treatment factors.",
author = "Thomas K{\"u}hne and Buchanan, {George R.} and Sherri Zimmerman and Michaels, {Lisa A.} and Regina Kohan and Willi Berchtold and Paul Imbach",
year = "2003",
month = "11",
doi = "10.1067/S0022-3476(03)00535-3",
language = "English (US)",
volume = "143",
pages = "605--608",
journal = "Journal of Pediatrics",
issn = "0022-3476",
publisher = "Mosby Inc.",
number = "5",

}

TY - JOUR

T1 - A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the intercontinental childhood ITP study group

AU - Kühne, Thomas

AU - Buchanan, George R.

AU - Zimmerman, Sherri

AU - Michaels, Lisa A.

AU - Kohan, Regina

AU - Berchtold, Willi

AU - Imbach, Paul

PY - 2003/11

Y1 - 2003/11

N2 - Objective: To analyze prospectively the impact of age at diagnosis in childhood idiopathic thrombocytopenic purpura (ITP). Study design: International registry from June 1997 to May 2001, with analysis of data from baseline and 6-month-follow-up questionnaires. Results: Data from 2540 patients were analyzed, including 203 infants (7.6%), 1860 children ≥1 to <10 years of age (69.1%), and 477 children and adolescents between ≥10 and <16 years of age (17.7%). The mean platelet count at diagnosis was similar in all three groups, as was the percentage of patients with initial platelet count <20 × 109/L. The male/female ratio was highest in infants and decreased with age (P = .009). Immunoglobulin therapy was used more often in infants and corticosteroids in patients ≥10 years of age. Follow-up information at 6 months was available for 1742 children (68.6%). Chronic ITP was seen less frequently in infants (23.1%) than in children >10 years of age (47.3%, P < .0001). Intracranial hemorrhage occurred in 3 of 1742 children during the first 6 months after the diagnosis of ITP. Conclusions: Pediatric patients with ITP from infancy to adolescence exhibit heterogeneity in clinical, demographic, and treatment factors.

AB - Objective: To analyze prospectively the impact of age at diagnosis in childhood idiopathic thrombocytopenic purpura (ITP). Study design: International registry from June 1997 to May 2001, with analysis of data from baseline and 6-month-follow-up questionnaires. Results: Data from 2540 patients were analyzed, including 203 infants (7.6%), 1860 children ≥1 to <10 years of age (69.1%), and 477 children and adolescents between ≥10 and <16 years of age (17.7%). The mean platelet count at diagnosis was similar in all three groups, as was the percentage of patients with initial platelet count <20 × 109/L. The male/female ratio was highest in infants and decreased with age (P = .009). Immunoglobulin therapy was used more often in infants and corticosteroids in patients ≥10 years of age. Follow-up information at 6 months was available for 1742 children (68.6%). Chronic ITP was seen less frequently in infants (23.1%) than in children >10 years of age (47.3%, P < .0001). Intracranial hemorrhage occurred in 3 of 1742 children during the first 6 months after the diagnosis of ITP. Conclusions: Pediatric patients with ITP from infancy to adolescence exhibit heterogeneity in clinical, demographic, and treatment factors.

UR - http://www.scopus.com/inward/record.url?scp=0345305368&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0345305368&partnerID=8YFLogxK

U2 - 10.1067/S0022-3476(03)00535-3

DO - 10.1067/S0022-3476(03)00535-3

M3 - Article

C2 - 14615730

AN - SCOPUS:0345305368

VL - 143

SP - 605

EP - 608

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

IS - 5

ER -